Monday, June 15, 2026

Latest:

How Medicare Advantage Rebates Disadvantage Medicare’s Stand-Alone Drug Plan Market
Medicare Part D Enrollment, Premiums, and Cost Sharing in 2026
What to know about MultiPlan’s litigation saga
Integrated data drives better care for homeless Veterans
States show dramatic ACA enrollment drop-offs: 5 notes

Home
About
- AMAC Foundation
What is medicare?
Enrolling in Medicare
Medicare History
- Medicare’s Major Milestones
COVID-19 Information

Part D/Prescription Drugs

Eileen Cook July 29, 2025July 29, 2025 CMS, Healthcare Costs, Healthcare Finance, Medicare Part D

2026 Medicare Part D Bid Information

The Centers for Medicare & Medicaid Services (CMS) has released preliminary technical Medicare Part D bid information for the 2026

CMS Health Care Finance Medicaid Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook July 29, 2025July 29, 2025 CMS, Healthcare Costs, Healthcare Finance, medicare, Medicare Advantage, Medicare Part D, MedPAC, Older Adults

Medicare Advantage in 2025: Enrollment Update and Key Trends

(By Nancy Ochieng, Meredith Freed, Jeannie Fuglesten Biniek, Anthony Damico, and Tricia Neuman for The Kaiser Family Foundation Published: Jul

Health Care Finance Health Care Redesign Legislative Update Part D/Prescription Drugs

Eileen Cook July 29, 2025July 29, 2025 340B drug discount program, Healthcare Costs, Healthcare Finance, Healthcare redesign, Medicare Part D

How health systems are preparing for a potential 340B overhaul

(By: Alexandra Murphy for Becker’s Hospital Review) As federal scrutiny and legislative proposals continue around the 340B drug pricing program,

CMS Health Care Finance Medicare Advantage Part D/Prescription Drugs

Eileen Cook July 17, 2025July 17, 2025 CMS, medicare, Medicare Advantage, Medicare Part D, Older Adults

The Uncertain Future of Medicare’s Stand-Alone Prescription Drug Plan Market and Why It Matters

(By Juliette Cubanski and Tricia Neuman for KFF Health News Published: Jul 16, 2025) Ahead of Medicare’s annual mid-year announcement

CMS Health Care Finance Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook July 17, 2025July 17, 2025 CMS, medicare, Medicare Advantage, Medicare Part D, Older Adults

Key Facts About Medicare Part D Enrollment, Premiums, and Cost Sharing in 2025

(By Juliette Cubanski and Anthony Damico for The Kaiser Family Foundation Published: Jul 16, 2025) The Medicare Part D program

FDA Health Care - General Part D/Prescription Drugs

Eileen Cook July 14, 2025July 14, 2025 Drug Shortages, FDA, Generic injectables, Injectable steroids, IV fluids, Lorazepam injection

4 pressing drug shortages

(By: Alexandra Murphy for Becker’s Hospital Review) While the total number of drug shortages in the U.S. appears to be decreasing

CMS Health Care Finance Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook July 10, 2025July 10, 2025 CMS, medicare, Medicare Advantage, Medicare Part D, Medicare Prescription Cap, Older Adults

What is the Medicare prescription cap

Two types of Medicare plans cover your prescription drug needs: Stand-alone Medicare Part D plans or Medicare Advantage prescription drug

Health Care Finance Legislative Update Part D/Prescription Drugs PBM's

Eileen Cook June 24, 2025June 24, 2025 Healthcare Costs, Healthcare Finance, Medicare Part D, PBM Industry

The Trump administration’s approach to PBMs, so far: 5 things to know

(By: Rylee Wilson for Becker’s Hospital Review) President Donald Trump has signed two executive orders aimed at reducing the cost

FDA Part D/Prescription Drugs

Eileen Cook June 20, 2025June 20, 2025 Drug Shortages, FDA

194 drugs currently in shortage: FDA

(By: Alexandra Murphy for Becker’s Hospital Review) Nationwide, hospitals and pharmacies are seeing ongoing shortages of medications including some anesthetics,

FDA Health Care Finance Legislative Update Part D/Prescription Drugs

Eileen Cook June 18, 2025June 18, 2025 Drug Manufacturing, Drug Shortages, Healthcare Finance, The Rolling Active Pharmaceutical Ingredient and Drug Reserve Act

Senate bill aims to rebuild drug manufacturing infrastructure: 3 notes

(By: Alexandra Murphy for Becker’s Hospital Review) A bipartisan group of U.S. senators has reintroduced a bill designed to address

← Previous
Next →